UK DERMATOLOGY CLINICAL TRIALS NETWORK (UK DCTN)
The main purpose of the UKDCTN is to conduct independent, high quality, multi-centre clinical trials to answer questions of importance to clinicians and patients in dermatology. The Network is open to trial suggestions from anyone with an interest in skin disease. The Network provides 'hands on' advice and guidance in developing clinical trials. All UKDCTN trials are non-commercial.
Objects
THE RELIEF OF SICKNESS AND THE PRESERVATION AND PROTECTION OF GOOD HEALTH IN CONNECTION WITH THE TREATMENT AND PREVENTION OF SKIN DISEASES.
Financial health, per its FY2026 accounts
The accounts have been examined by an independent examiner who confirmed that no material matters came to their attention suggesting non-compliance with accounting records or the accounts themselves. The examiner stated there were no other matters requiring attention for a proper understanding of the accounts. The document does not provide specific financial figures regarding reserves, income, or expenditure.
What the accounts disclose
Policies the charity declares
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
Trustees
- Dr Abby Elizabeth Macbeth
- Dr CARRON PATRICIA LAYFIELD
- Dr Evelyn Louise Davies
- Dr Jane Sterling
- Dr KIM SUZANNE THOMAS
- Dr Rubeta Matin
- Melanie Jane Westmoreland
- PROFESSOR HYWEL WILLIAMS
- Professor Beth Stuart
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2026 | £26k | £20k |
| 31/03/2025 | £20k | £26k |
| 31/03/2024 | £24k | £21k |
| 31/03/2023 | £24k | £19k |
| 31/03/2022 | £23k | £26k |
Common questions
Is UK DERMATOLOGY CLINICAL TRIALS NETWORK (UK DCTN) financially healthy?
Per its FY2026 accounts: The accounts have been examined by an independent examiner who confirmed that no material matters came to their attention suggesting non-compliance with accounting records or the accounts themselves. The examiner stated there were no other matters requiring attention for a proper understanding of the accounts. The document does not provide specific financial figures regarding reserves, income, or expenditure. Its FY2026 accounts were independently examined.